Controllability and Real Life Efficacy of Bonviva 3 mg iv Quarterly vs. Oral Alendronate Generics.

Trial Profile

Controllability and Real Life Efficacy of Bonviva 3 mg iv Quarterly vs. Oral Alendronate Generics.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 May 2015

At a glance

  • Drugs Ibandronic acid (Primary) ; Alendronic acid
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Acronyms VIVA
  • Sponsors Roche
  • Most Recent Events

    • 06 Jul 2012 Actual patient number 6054 added as reported by ClinicalTrials.gov.
    • 06 Jul 2012 Actual end date Mar 2012 added as reported by ClinicalTrials.gov.
    • 06 Jul 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top